Influence of intensive glycemic control on development and progression of diabetic nephropathy in patients with type 2 diabetes mellitus (based on results from ADVANCE study)
Current article presents data on effects of intensive glycemic control with Diabeton MR on development and progression of diabetic nephropathy in patients with type 2 diabetes mellitus (T2DM), accumulated from ADVANCE (Action in Diabetes and Vascular Disease: Preterax and DiamicroN Modified Release Controlled Evaluation study). Influence of intensive therapy with Diabeton MR was assessed in that study separately and in conjunction with active antihypertensive treatment with perindopril and indapamide.